Quorum-Sensing Inhibitor Composition for Biofilm Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The increasing bacterial resistance to conventional antibiotics necessitates the development of novel antibacterial agents that interfere with bacterial communication pathways, such as quorum sensing, to inhibit virulence and biofilm formation without promoting resistance development.
Innovation Solution
A composition comprising Tryptophol acetate and Tyrosol acetate, along with a microorganism mixture including Kluyveromyces marxianus and probiotic microorganisms, is used to disrupt quorum sensing and reduce biofilm production, offering an alternative to traditional antibiotics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibiotics are used to treat bacterial infections, then bacterial killing or inhibition is achieved, but bacterial resistance develops
Solution Approach 1:
The patent converts the harmful effect of quorum sensing (bacterial communication that regulates virulence and biofilm formation) into a beneficial target for intervention. By developing quorum sensing inhibitors that disrupt this communication pathway, the invention achieves antibacterial effects without the selective pressure that drives resistance development, thus converting the problem of bacterial communication into a solution for sustainable antimicrobial therapy
Solution Approach 2:
The patent changes the fundamental parameter of antibacterial action from direct killing (antibiotics) to indirect inhibition (quorum sensing disruption). This parameter change involves targeting the regulatory signaling pathways that control bacterial virulence and biofilm formation, thereby achieving therapeutic effects through a different mechanism that does not promote resistance
2Reliability
If quorum sensing pathways are interfered with to inhibit virulence, then antibacterial activity is achieved, but the mechanism is novel and unproven
Solution Approach 1:
The patent performs preliminary validation of the quorum sensing interference mechanism through in vitro assays demonstrating inhibition of biofilm formation and virulence factor production. These preliminary results provide proof of concept that the novel mechanism works, reducing the uncertainty associated with unproven approaches and building a foundation for further development and clinical validation
3Reliability
If Tryptophol acetate and Tyrosol acetate are used in combination, then synergistic anti-inflammatory and anti-amyloid effects are achieved, but the optimal ratio must be determined
Solution Approach 1:
The patent changes the formulation parameter by establishing an optimal weight ratio (10:1 to 1:10) between Tryptophol acetate and Tyrosol acetate. This parameter optimization simplifies the composition formulation by providing a defined ratio range that achieves synergistic effects, reducing the complexity of determining precise formulations while maintaining therapeutic efficacy
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively inhibits bacterial biofilm formation and reduces inflammatory and amyloid-related diseases, demonstrating anti-inflammatory and anti-amyloid aggregation activities, while potentially avoiding resistance development.
Implementation Method 1
Interference with bacterial communication pathways, also known as 'quorum sensing' (QS). QS bacteria release chemical molecules termed 'autoinducers' which in many instances affect gene expression in neighboring bacterial cells
Implementation Method 2
demonstrating anti-inflammatory and anti-amyloid aggregation activities
Implementation Method 3
demonstrating anti-inflammatory and anti-amyloid aggregation activities
Data Source
Figure 1A~2A
Figure 2B~3A
Figure 3B~4A
AI summary
The present invention is directed to a composition comprising a Tryptophol derivative and a 4-Ethyl-Phenol derivative, and at least one acceptable carrier. Further provided are methods for reducing the formation of load of organic-based contaminant.